Review



fractalkine specific sirna  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Santa Cruz Biotechnology fractalkine specific sirna
    Fig. 3. Immunoblot analysis of fractalkine protein expression in HUVECs after silencing NF-κB p65. HUVECs were transfected with NF-κB p65 <t>siRNA</t> or control siRNA (Cont siRNA) and treated with TNF-α with or without EGCG (50 µmol/L) for 6 h. Actin was used as the loading control. Densitometric analyses are presented as the relative ratio of fractalkine to actin. The relative ratio compared to the control is arbitrarily defined as 1. Note that silencing NF-κB p65 reduced TNF-α-induced fractalkine protein expression. Bars represent the mean±SD from 3 different experiments. *, p<0.05 vs. Cont siRNA only; #, p<0.05 vs. TNF-α plus Cont siRNA.
    Fractalkine Specific Sirna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fractalkine specific sirna/product/Santa Cruz Biotechnology
    Average 86 stars, based on 1 article reviews
    fractalkine specific sirna - by Bioz Stars, 2026-02
    86/100 stars

    Images

    1) Product Images from "Epigallocatechin-3-O-gallate decreases tumor necrosis factor-alpha-induced fractalkine expression in endothelial cells by suppressing NF-kappaB."

    Article Title: Epigallocatechin-3-O-gallate decreases tumor necrosis factor-alpha-induced fractalkine expression in endothelial cells by suppressing NF-kappaB.

    Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology

    doi: 10.1159/000257494

    Fig. 3. Immunoblot analysis of fractalkine protein expression in HUVECs after silencing NF-κB p65. HUVECs were transfected with NF-κB p65 siRNA or control siRNA (Cont siRNA) and treated with TNF-α with or without EGCG (50 µmol/L) for 6 h. Actin was used as the loading control. Densitometric analyses are presented as the relative ratio of fractalkine to actin. The relative ratio compared to the control is arbitrarily defined as 1. Note that silencing NF-κB p65 reduced TNF-α-induced fractalkine protein expression. Bars represent the mean±SD from 3 different experiments. *, p<0.05 vs. Cont siRNA only; #, p<0.05 vs. TNF-α plus Cont siRNA.
    Figure Legend Snippet: Fig. 3. Immunoblot analysis of fractalkine protein expression in HUVECs after silencing NF-κB p65. HUVECs were transfected with NF-κB p65 siRNA or control siRNA (Cont siRNA) and treated with TNF-α with or without EGCG (50 µmol/L) for 6 h. Actin was used as the loading control. Densitometric analyses are presented as the relative ratio of fractalkine to actin. The relative ratio compared to the control is arbitrarily defined as 1. Note that silencing NF-κB p65 reduced TNF-α-induced fractalkine protein expression. Bars represent the mean±SD from 3 different experiments. *, p<0.05 vs. Cont siRNA only; #, p<0.05 vs. TNF-α plus Cont siRNA.

    Techniques Used: Western Blot, Expressing, Transfection, Control

    Fig. 6. EGCG reduces adhesion of monocytes to HUVEC monolayers. (A) Representative images of the adhesion of monocytes to HUVEC monolayers. HUVECs were incubated with the indicated doses of EGCG, fractalkine-specific siRNA, control siRNA, antibody against fractalkine, control antibody (Cont antibody) and TNF-α (10 ng/mL) for 4 h. Fluorescence-labelled monocytes were added to the HUVEC monolayer and allowed to adhere for 2 h. The adhered cells were measured as described in Materials and Methods. (B) Quantification of monocyte adhesion to HUVECs. Data are from three experiments and are expressed as a percentage of adhesion to TNF-α-induced HUVECs. Bars represent the mean±SD from three experiments. *, p<0.05 vs. control (CB); #, p<0.05 vs. TNF-α.
    Figure Legend Snippet: Fig. 6. EGCG reduces adhesion of monocytes to HUVEC monolayers. (A) Representative images of the adhesion of monocytes to HUVEC monolayers. HUVECs were incubated with the indicated doses of EGCG, fractalkine-specific siRNA, control siRNA, antibody against fractalkine, control antibody (Cont antibody) and TNF-α (10 ng/mL) for 4 h. Fluorescence-labelled monocytes were added to the HUVEC monolayer and allowed to adhere for 2 h. The adhered cells were measured as described in Materials and Methods. (B) Quantification of monocyte adhesion to HUVECs. Data are from three experiments and are expressed as a percentage of adhesion to TNF-α-induced HUVECs. Bars represent the mean±SD from three experiments. *, p<0.05 vs. control (CB); #, p<0.05 vs. TNF-α.

    Techniques Used: Incubation, Control, Fluorescence



    Similar Products

    cx3cl1 fractalkine specific sirna  (Thermo Fisher)
    86
    Thermo Fisher cx3cl1 fractalkine specific sirna
    Cx3cl1 Fractalkine Specific Sirna, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cx3cl1 fractalkine specific sirna/product/Thermo Fisher
    Average 86 stars, based on 1 article reviews
    cx3cl1 fractalkine specific sirna - by Bioz Stars, 2026-02
    86/100 stars
    		  Buy from Supplier
    fractalkine specific sirna  (Santa Cruz Biotechnology)
    86
    Santa Cruz Biotechnology fractalkine specific sirna
    Fig. 3. Immunoblot analysis of fractalkine protein expression in HUVECs after silencing NF-κB p65. HUVECs were transfected with NF-κB p65 <t>siRNA</t> or control siRNA (Cont siRNA) and treated with TNF-α with or without EGCG (50 µmol/L) for 6 h. Actin was used as the loading control. Densitometric analyses are presented as the relative ratio of fractalkine to actin. The relative ratio compared to the control is arbitrarily defined as 1. Note that silencing NF-κB p65 reduced TNF-α-induced fractalkine protein expression. Bars represent the mean±SD from 3 different experiments. *, p<0.05 vs. Cont siRNA only; #, p<0.05 vs. TNF-α plus Cont siRNA.
    Fractalkine Specific Sirna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fractalkine specific sirna/product/Santa Cruz Biotechnology
    Average 86 stars, based on 1 article reviews
    fractalkine specific sirna - by Bioz Stars, 2026-02
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    Fig. 3. Immunoblot analysis of fractalkine protein expression in HUVECs after silencing NF-κB p65. HUVECs were transfected with NF-κB p65 siRNA or control siRNA (Cont siRNA) and treated with TNF-α with or without EGCG (50 µmol/L) for 6 h. Actin was used as the loading control. Densitometric analyses are presented as the relative ratio of fractalkine to actin. The relative ratio compared to the control is arbitrarily defined as 1. Note that silencing NF-κB p65 reduced TNF-α-induced fractalkine protein expression. Bars represent the mean±SD from 3 different experiments. *, p<0.05 vs. Cont siRNA only; #, p<0.05 vs. TNF-α plus Cont siRNA.

    Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology

    Article Title: Epigallocatechin-3-O-gallate decreases tumor necrosis factor-alpha-induced fractalkine expression in endothelial cells by suppressing NF-kappaB.

    doi: 10.1159/000257494

    Figure Lengend Snippet: Fig. 3. Immunoblot analysis of fractalkine protein expression in HUVECs after silencing NF-κB p65. HUVECs were transfected with NF-κB p65 siRNA or control siRNA (Cont siRNA) and treated with TNF-α with or without EGCG (50 µmol/L) for 6 h. Actin was used as the loading control. Densitometric analyses are presented as the relative ratio of fractalkine to actin. The relative ratio compared to the control is arbitrarily defined as 1. Note that silencing NF-κB p65 reduced TNF-α-induced fractalkine protein expression. Bars represent the mean±SD from 3 different experiments. *, p<0.05 vs. Cont siRNA only; #, p<0.05 vs. TNF-α plus Cont siRNA.

    Article Snippet: Fractalkine-specific siRNA (Santa Cruz Biotechnology, Santa Cruz, CA, USA), NF-κB p65 siRNA (human specific) (Cell Signaling Technology), negative control siRNA (Dharmacon Research, Lafayette, CO, USA) were used.

    Techniques: Western Blot, Expressing, Transfection, Control

    Fig. 6. EGCG reduces adhesion of monocytes to HUVEC monolayers. (A) Representative images of the adhesion of monocytes to HUVEC monolayers. HUVECs were incubated with the indicated doses of EGCG, fractalkine-specific siRNA, control siRNA, antibody against fractalkine, control antibody (Cont antibody) and TNF-α (10 ng/mL) for 4 h. Fluorescence-labelled monocytes were added to the HUVEC monolayer and allowed to adhere for 2 h. The adhered cells were measured as described in Materials and Methods. (B) Quantification of monocyte adhesion to HUVECs. Data are from three experiments and are expressed as a percentage of adhesion to TNF-α-induced HUVECs. Bars represent the mean±SD from three experiments. *, p<0.05 vs. control (CB); #, p<0.05 vs. TNF-α.

    Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology

    Article Title: Epigallocatechin-3-O-gallate decreases tumor necrosis factor-alpha-induced fractalkine expression in endothelial cells by suppressing NF-kappaB.

    doi: 10.1159/000257494

    Figure Lengend Snippet: Fig. 6. EGCG reduces adhesion of monocytes to HUVEC monolayers. (A) Representative images of the adhesion of monocytes to HUVEC monolayers. HUVECs were incubated with the indicated doses of EGCG, fractalkine-specific siRNA, control siRNA, antibody against fractalkine, control antibody (Cont antibody) and TNF-α (10 ng/mL) for 4 h. Fluorescence-labelled monocytes were added to the HUVEC monolayer and allowed to adhere for 2 h. The adhered cells were measured as described in Materials and Methods. (B) Quantification of monocyte adhesion to HUVECs. Data are from three experiments and are expressed as a percentage of adhesion to TNF-α-induced HUVECs. Bars represent the mean±SD from three experiments. *, p<0.05 vs. control (CB); #, p<0.05 vs. TNF-α.

    Article Snippet: Fractalkine-specific siRNA (Santa Cruz Biotechnology, Santa Cruz, CA, USA), NF-κB p65 siRNA (human specific) (Cell Signaling Technology), negative control siRNA (Dharmacon Research, Lafayette, CO, USA) were used.

    Techniques: Incubation, Control, Fluorescence